1887

Abstract

Tumour necrosis factor (TNF) is an important cytokine in the innate immune response against various infections, including herpes simplex virus (HSV) infection. It has recently become a molecular target of anti-cytokine treatment in certain inflammatory diseases. TNF depletion resulted in a more rapid emergence of infectious HSV-1 in the explant cultures of latently infected trigeminal ganglia (TG), compared with controls. To further evaluate the importance of TNF in the host's defence responses against HSV-1, TNF-knockout mice were challenged via scarified cornea. These mice were more susceptible to primary acute corneal HSV-1 infection than controls, as manifested by an increased mortality rate and higher infectious virus titres in the eyes and TG, indicating that TNF is critical for defence during acute HSV infection. These results imply that the administration of anti-inflammatory TNF antagonists might facilitate the propagation of infectious HSV, resulting in an exacerbation of primary and recurrent acute lesions.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19627-0
2004-02-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/2/vir850343.html?itemId=/content/journal/jgv/10.1099/vir.0.19627-0&mimeType=html&fmt=ahah

References

  1. Cantin, E. M., Hinton, D. R., Chen, J. & Openshaw, H. ( 1995; ). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 69, 4898–4905.
    [Google Scholar]
  2. Chen, S. H., Garber, D. A., Schaffer, P. A., Knipe, D. M. & Coen, D. M. ( 2000; ). Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology 278, 207–216.[CrossRef]
    [Google Scholar]
  3. Feldman, L. T., Ellison, A. R., Voytek, C. C., Yang, L., Krause, P. & Margolis, T. P. ( 2002; ). Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A 99, 978–983.[CrossRef]
    [Google Scholar]
  4. Fox, D. A. ( 2000; ). Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor. Arch Intern Med 160, 437–444.[CrossRef]
    [Google Scholar]
  5. Gardam, M. A., Keystone, E. C., Menzies, R., Manners, S., Skamene, E., Long, R. & Vinh, D. C. ( 2003; ). Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3, 148–155.[CrossRef]
    [Google Scholar]
  6. Ghiasi, H., Perng, G., Nesburn, A. B. & Wechsler, S. L. ( 1999; ). Either a CD4+ or CD8+ T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Microb Pathog 27, 387–394.[CrossRef]
    [Google Scholar]
  7. Halford, W. P., Gebhardt, B. M. & Carr, D. J. ( 1996; ). Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 157, 3542–3549.
    [Google Scholar]
  8. Herbein, G. & O'Brien, W. A. ( 2000; ). Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med 223, 241–257.[CrossRef]
    [Google Scholar]
  9. Hirano, T. ( 1998; ). Interleukin-6. In The Cytokine Handbook, 3rd edn, pp. 197–228. Edited by A. Thomson. San Diego: Academic Press.
  10. Jones, C. ( 2003; ). Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev 16, 79–95.[CrossRef]
    [Google Scholar]
  11. Kasahara, S., Ando, K. Saito, K. & 7 other authors ( 2003; ). Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol 77, 2469–2476.[CrossRef]
    [Google Scholar]
  12. Koelle, D. M. & Corey, L. ( 2003; ). Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 16, 96–113.[CrossRef]
    [Google Scholar]
  13. Kriesel, J. D., Gebhardt, B. M., Hill, J. M., Maulden, S. A., Hwang, I. P., Clinch, T. E., Cao, X., Spruance, S. L. & Araneo, B. A. ( 1997; ). Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J Infect Dis 175, 821–827.[CrossRef]
    [Google Scholar]
  14. LeBlanc, R. A., Pesnicak, L., Cabral, E. S., Godleski, M. & Straus, S. E. ( 1999; ). Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. J Virol 73, 8145–8151.
    [Google Scholar]
  15. Liu, T., Tang, Q. & Hendricks, R. L. ( 1996; ). Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 70, 264–271.
    [Google Scholar]
  16. Liu, T., Khanna, K. M., Chen, X., Fink, D. J. & Hendricks, R. L. ( 2000; ). CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191, 1459–1466.[CrossRef]
    [Google Scholar]
  17. Liu, T., Khanna, K. M., Carriere, B. N. & Hendricks, R. L. ( 2001; ). Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 75, 11178–11184.[CrossRef]
    [Google Scholar]
  18. Minagawa, H. & Yanagi, Y. ( 2000; ). Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+ T cells: a new model for latency. Arch Virol 145, 2259–2272.[CrossRef]
    [Google Scholar]
  19. Minagawa, H., Tanaka, S., Toh, Y. & Mori, R. ( 1994; ). Detection of herpes simplex virus type 1-encoded RNA by polymerase chain reaction: different pattern of viral RNA detection in latently infected murine trigeminal ganglia following in vitro or in vivo reactivation. J Gen Virol 75, 647–650.[CrossRef]
    [Google Scholar]
  20. Minagawa, H., Sakai, Y., Li, Y. Y., Ishibashi, T., Inomata, H. & Mori, R. ( 1997; ). Suppression of infectious virus spread and corneal opacification by the combined use of recombinant interferon beta and interleukin-10 following corneal infection with herpes simplex virus-1 in mice. Antiviral Res 36, 99–105.[CrossRef]
    [Google Scholar]
  21. Minami, M., Kita, M., Yan, X. Q., Yamamoto, T., Iida, T., Sekikawa, K., Iwakura, Y. & Imanishi, J. ( 2002; ). Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection. J Interferon Cytokine Res 22, 671–676.[CrossRef]
    [Google Scholar]
  22. Noisakran, S. & Carr, D. J. ( 1999; ). Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia. J Neuroimmunol 95, 126–135.[CrossRef]
    [Google Scholar]
  23. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. ( 1996; ). Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184, 1397–1411.[CrossRef]
    [Google Scholar]
  24. Rossol-Voth, R., Rossol, S., Schutt, K. H., Corridori, S., de Cian, W. & Falke, D. ( 1991; ). In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J Gen Virol 72, 143–147.[CrossRef]
    [Google Scholar]
  25. Schmitt, D. A., Sasaki, H., Pollard, R. B. & Suzuki, F. ( 1992; ). Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1. Antiviral Res 19, 347–352.[CrossRef]
    [Google Scholar]
  26. Shimeld, C., Whiteland, J. L., Williams, N. A., Easty, D. L. & Hill, T. J. ( 1997; ). Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J Gen Virol 78, 3317–3325.
    [Google Scholar]
  27. Shimeld, C., Easty, D. L. & Hill, T. J. ( 1999; ). Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines. J Virol 73, 1767–1773.
    [Google Scholar]
  28. Trevejo, J. M., Marino, M. W., Philpott, N., Josien, R., Richards, E. C., Elkon, K. B. & Falck-Pedersen, E. ( 2001; ). TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci U S A 98, 12162–12167.[CrossRef]
    [Google Scholar]
  29. Wagner, E. K. & Bloom, D. C. ( 1997; ). Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 10, 419–443.
    [Google Scholar]
  30. Walev, I., Podlech, J. & Falke, D. ( 1995; ). Enhancement by TNF-alpha of reactivation and replication of latent herpes simplex virus from trigeminal ganglia of mice. Arch Virol 140, 987–992.[CrossRef]
    [Google Scholar]
  31. White, D. W., Badovinac, V. P., Kollias, G. & Harty, J. T. ( 2000; ). Cutting edge: antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice. J Immunol 165, 5–9.[CrossRef]
    [Google Scholar]
  32. Whitley, R. J. ( 2001; ). Herpes simplex viruses. In Fields Virology, 4th edn, pp. 2461–2509. Edited by D. Knipe & P. Howley. Philadelphia: Lippincott Williams & Wilkins.
  33. Wong, G. H. W. & Goeddel, D. V. ( 1986; ). Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323, 819–822.[CrossRef]
    [Google Scholar]
  34. Zhang, M. & Tracey, K. J. ( 1998; ). Tumor necrosis factor. In The Cytokine Handbook, 3rd edn, pp. 517–548. Edited by A. Thomson. San Diego: Academic Press.
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19627-0
Loading
/content/journal/jgv/10.1099/vir.0.19627-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error